Cerebrospinal fluid vasopressin levels. Correlates with aggression and serotonin function in personality-disordered subjects

Archives of General Psychiatry

Volumn 55, Issue 8, 1998, Pages 708-714

  Coccaro, Emil F ^a   Kavoussi, Richard J ^a   Hauger, Richard L ^b   Cooper, Thomas B ^c,d   Ferris, Craig F ^e  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; DEXFENFLURAMINE; PROLACTIN; SEROTONIN; VASOPRESSIN;

ADULT; AGGRESSION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; MALE; NEUROPSYCHOLOGY; PERSONALITY DISORDER; PROLACTIN RELEASE; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM;

ADULT; AGGRESSION; ARGININE VASOPRESSIN; FEMALE; FENFLURAMINE; HUMANS; HYDROXYINDOLEACETIC ACID; IMPULSIVE BEHAVIOR; MALE; MENTAL DISORDERS; PERSONALITY DISORDERS; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN;

EID: 0031880584     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.8.708     Document Type: Article

References (60)

1. Coccaro EF, Kavoussi RJ. Neurotransmitter correlates of aggression. In: Stoff DM, Cairns RB, eds. The Neurobiology of Clinical Aggression. Mahwah, NJ: Lawrence J. Erlbaum Associates, Inc; 1996:67-85.
2. Depue RA, Spoont MR. Conceptualizing a serotonin trait: a behavioral dimension of constraint. Ann N Y Acad Sci. 1986;487:47-62.
3. Eichelman B, Barchus J. Facilitated shock-induced aggression following antidepressant medication in the rat. Pharmacol Biochem Behav. 1975;3:601-604.
4. Stolk JM, Conner RL, Levine S, Barchas JD. Brain norepinephrine metabolism and shock-induced fighting behavior in rats: differential effects of shock and fighting on the neurochemical response to a common footshock stimulus. J Pharmacol Exp Ther. 1984;190:193-209.
5. Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ. Growth hormone responses to intravenous clonidine challenge correlates with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res. 1991; 39:129-139.
6. Datla KP, Sen AP, Bhattacharya SK. Dopaminergic modulation of footshock induced aggression in paired rats. Indian J Exp Biol. 1992;30:587-591.
7. Ordway GA, Widdowson PS, Smith KS, Halaris A. Agonist binding to alpha-2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem. 1994;63:617-624.
8. Post RM, Pickar, D, Ballenger JC, Naber D, Rubinow DR. Endogenous opiates in cerebrospinal fluid: relationship to mood and anxiety. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore, Md: Williams & Wilkins, 1984: 356-368.
9. Coid J, Allolio B, Rees LH. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet. 1983;2:545-546.
10. Archer J. The influence of testosterone on human aggression. Br J Psychol. 1991; 82:1-28.
11. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen SL, Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry. 1994;51:20-27.
12. Higley JD, Mehlman PT, Taub DM, Higley SB, Suomi SJ, Vickers JH, Linnoila M. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry. 1992;49:436-441.
13. Ferris CF, Potegal M. Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters. Physiol Behav. 1988;44:235-239.
14. Potegal M, Ferris CF. Intraspecific aggression in male hamsters is inhibited by intrahypothalamic vasopressin-receptor antagonist. Aggressive Behav. 1989; 15:311-320.
15. Ferris CF, Delville Y. Vasopressin and serotonin interactions in the control of agonistic behavior. Psychoneuroendocrinology. 1994;19:593-601.
16. Ferris CF. Serotonin diminishes aggression by suppressing the activity of the vasopressin system. Ann N Y Acad Sci. 1996;794:98-103.
17. Delville Y, Mansour KM, Ferris CF. Serotonin blocks vasopressin-facilitated offensive aggression: interactions within the ventrolateral hypothalamus of golden hamsters. Physiol Behav. 1996;59:813-816.
18. Ferris CF, Meloni RH, Koppel G, Perry KW, Fuller RW, Delville Y. Vasopressin/ serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci. 1997;17:4331-4340.
19. Koolhaus JM, Van den Brink THC, Roozendal B, Boorsma F. Medial amygdala and aggressive behavior: interaction between testosterone and vasopressin. Aggressive Behav. 1990;16:223-229.
20. Koolhaus JM, Moor E, Hiemstra Y, Bohus B. The testosterone-dependent vasopressinergic neurons in the medial amygdala and lateral septum: involvement in social behavior of male rats. In: Jard S, Jamison R, eds. Vasopressin. Paris, France: INSERM/John Libbey Eurotext Ltd; 1991:213-219.
21. Haller J, Makara GB, Barna I, Kovacs K, Nagy J. Compression of the pituitary stalk elicits chronic increases in CSF vasopressin, oxytocin as well as in social investigation and aggressiveness. J Neuroendocrinol. 1996;8:361-365.
22. Winslow JT, Hastings N, Carter CS, Haraugh CR, Insel TR. A role for central vasopressin in pair bonding in monogamous prairie voles. Nature. 1993;365: 545-548.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
24. Coccaro EF, Siever LJ, Klar H, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL. Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry. 1989;46:587-599.
25. Coccaro EF, Kavoussi RJ, Berman ME, Hauger RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality disordered males. Biol Psychiatry. 1996;40:157-164.
26. Coccaro EF, Berman ME, Kavoussi RJ. Assessment of life history of aggression: development and psychometric characteristics. Psychiatry Res. 1997;73:147-157.
27. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best estimate of lifetime psychiatric diagnosis: a methodologic study. Arch Gen Psychiatry. 1982;39:879-883.
28. Klein DN, Ouimette PC, Kelly HS, Ferro T, Riso LP. Test-retest reliability of a team consensus best-estimate diagnoses of Axis I and II disorders in a family study. Am J Psychiatry. 1994;151:1043-1047.
29. Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol. 1995;51:768-774.
30. Guy W. ECDEU Manual for Psychopharmacology. Washington, DC: US Dept of Health, Education, and Welfare; 1976. Publication ADM 76-338.
31. Spielberger CD. Manual for the State-Trait Anxiety Inventory: STAI (Form Y). Palo Alto, Calif: Consulting Psychologists Press; 1983.
32. Ferris CF, Pilapil G, Hayden-Hixson D, Wiley RG, Koh ET. Functionally and anatomically distinct populations of vasopressinergic magnocellualr neurons in the female golden hamster. J Neuroendocrinol. 1992;4:193-205.
33. Fri C-G, Wiesel F-A, Sedvall G. Simultaneous qunatification of homovanillic acid and 5-hydroxyindolacetic acid in cerebrospinal fluid by mass fragmentography. Life Sci. 1974;14:2469-2480.
34. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin and aggression: inverse relationship with prolactin response to d-fenfluramine, but not with CSF 5-HIAA concentration in human subjects. Am J Psychiatry. 1997;154:1430-1435.
35. Krebs HA, Chens LK, Wright GJ. Determination of fenfluramine and norfenfluramine in plasma using a nitrogen-sensitive detector. J Chromatogr. 1984;310: 412-417.
36. Delville Y, Mansour KM, Ferris CF. Testosterone facilitates aggression by modulating vasopressin receptors in the hypothalamus. Physiol Behav. 1996;60: 25-29.
37. Gold PW, Robertson GL, Ballenger JC, Rubinow DR, Kellner CR, Post RM, Goodwin FK. Neurohypophyseal function in affective illness. Psychopharmacol Bull. 1983;19:426-431.
38. Gjerris A, Hammer M, Vendsborg P, Christensen NJ, Raffelson OJ. Cerebrospinal fluid vasopressin changes in depression. Br J Psychiatry. 1985;145: 696-701.
39. Sorensen PS, Gjerris A, Hammer M. Cerebrospinal fluid vasopressin in neurological and psychiatric disorders. J Neurol Neurosurg Psychiatry. 1985;48:50-57.
40. Altemus M, Pigott T, Kalogeras KT, Demitrack M, Dubbert B, Murphy DL, Gold PW. Abnormalities on the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry. 1992; 49:9-20.
41. Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls D, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, Barr LC, Cohen DJ. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry. 1994;51:782-792.
42. Mazurek MF, Growdon JH, Beal MF, Martin JB. CSF vasopressin concentration is reduced in Alzheimer's disease. Neurology. 1986;36:1133-1137.
43. Raskind MA, Peskind ER, Lampe TH, Risse SC, Taborsky GJ, Dorsa D. Cerebrospinal fluid vasopressin, oxytocin, somatostatin, and beta-endorphin in Alzheimer's disease. Arch Gen Psychiatry. 1986;43:382-388.
44. Gold PW, Kaye W, Robertson GL, Ebert M. Abnormalities in plasma and cerebrospinal fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 1983;308:1117-1123.
45. Swedo SE, Leonard HL, Kruesi MJP, Rettew DC, Listwak SJ, Berrettini W, Stipetic M, Hamburger S, Gold PW, Potter WZ, Rapoport JL. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:29-36.
46. Sorensen PS, Vilhardt H, Gjerris F, Warberg J. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. Eur J Clin Invest. 1984; 14:435-439.
47. Sorenson PS, Hammer M. Vasopressin in plasma and ventricular cerebrospinal fluid during dehydration, postural changes, and nausea. Am J Physiol. 1985; 248:R78-R83.
48. Buijis RM. Vasopressin and oxytocin localization and putative functions in the brain. Acta Neurochir Suppl (Wien). 1990;47:86-89.
49. Brownfield MS, Kozlowski GP. The hypothalamochorioidal tract, I: immunohistochemical demonstration of neurophysin pathways to telencephalic choroid plexus and cerebrospinal fluid. Cell Tissue Res. 1977;178:111-127.
50. Schwartz WJ, Reppert SM. Neural regulation of the circadian vasopressin rhythm in cerebrospinal fluid: a preeminent role for the suprachiasmatic nuclei. J Neurosci. 1985;5:2771-2778.
51. Hammer M, Sorensen PS, Gjerris F, Larsen K. Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. Acta Endocrinol. 1982;100:211-215.
52. DeBellis MD, Gold PW, Geracioti TD, Listwak SJ, Kling MA. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am J Psychiatry. 1993;150:656-657.
53. Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. Arch Gen Psychiatry. 1994;51:794-803.
54. Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry. 1997;54:1081-1088.
55. Moss HB, Yao JK, Panzak GL. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry. 1990;28:325-338.
56. Coccaro EF, Gabriel S, Siever LJ. Buspirone challenge: preliminary evidence for a role for 5-HT-1a receptors in impulsive aggressive behavior in humans. Psychopharmacol Bull. 1990;26:393-405.
57. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 1992;160:643-646.
58. Coccaro EF, Klar HM, Siever LJ. Prolactin responsiveness to fenfluramine challenge does not correlate with prolactin responsiveness to TRH challenge in psychiatric patient. Biol Psychiatry. 1994;36:344-346.
59. Coccaro EF, Kavoussi RJ, Trestman RL, Gabriel SM, Cooper TB, Siever LJ. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res. 1997;73:1-14.
60. Moller SE, Mortensen EL, Breum L, Alling C, Larsen OG, Boge-Rasmussen T, Jensen C, Bennicke K. Aggression and personality: association with amino acids and monoamine metabolites. Psychol Med. 1996;26:323-331.